Personnel Changes at the FDA

Dr. Janet Woodcock will be the chief medical officer at the US Food and Drug Administration (Rockville, MD, www.fda.org). Dr. Woodcock most recently served as the deputy commissioner for operations. As the chief medical officer she will oversee scientific and planning-related operations for the agency.

John R. Dyer, MPH, will be FDA’s deputy commissioner for operations and the chief operating officer. Dyer will be a part of the senior management of the agency that supports the commissioner in advancing his priority initiatives and will concentrate on strengthening the management, business processes, and information technology of FDA.

Randall Lutter, PhD, will serve as acting deputy commissioner for policy. Lutter will replace Dr. Scott Gottlieb who recently announced his resignation. In this role, Lutter will provide guidance and input on all agency matters and serve as lead advisor to the commissioner on agency policy.

Dr. Shiew-Mei Huang will be the deputy director of the Office of Clinical Pharmacology. Dr. Shiew-Mei has been an FDA senior biomedical research scientist since 1998. She joined the Office of Clinical Pharmacology in 1996 and has held various positions of increasing responsibility since then.